Hubso (HUBSO) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
19 Jun, 2025Executive summary
Revenue for Q1 2025 was 52,389 SEK, a sharp decline from 3,709,938 SEK in Q1 2024, mainly due to discontinued operations and partnerships.
EBITDA improved to -186,777 SEK from -3,271,073 SEK year-over-year, reflecting cost-saving measures and restructuring.
Strategic review led to divestment of Sanne Alexandra Stockholm AB and ongoing evaluation of further business divestments.
Board initiated a control balance sheet after equity fell below half of registered share capital.
Financial highlights
Net sales for Q1 2025: 52,389 SEK (Q1 2024: 3,709,938 SEK).
EBITDA for Q1 2025: -186,777 SEK (Q1 2024: -3,271,073 SEK).
Cash and cash equivalents at March 31, 2025: 93,984 SEK (March 31, 2024: 11,500 SEK).
Equity at March 31, 2025: -15,162,139 SEK, indicating negative equity.
Earnings per share for Q1 2025: -0.002 SEK (Q1 2024: -0.07 SEK).
Outlook and guidance
Board and shareholders opted to continue operations to explore financing and potential reverse acquisition opportunities.
Acquisition agreement signed for Genair8 ApS, an AI platform provider for healthcare and social services, for up to 126.5 MSEK, pending shareholder and market approval.
Latest events from Hubso
- Net sales collapsed to zero, subsidiaries filed for bankruptcy, and a reverse acquisition is pending.HUBSO
Q2 202529 Aug 2025 - Revenue and profitability fell sharply, triggering a major restructuring and strategic reset.HUBSO
Q3 202413 Jun 2025 - Net sales fell sharply and margins contracted as HUBSO initiates major restructuring.HUBSO
Q2 202413 Jun 2025 - Revenue down 38% and equity depleted as HUBSO pursues urgent restructuring.HUBSO
Q4 20246 Jun 2025